It’s 2021, a COVID-19 vaccine is ready, what next for Nigeria?
Syringe in transit. Source: Stears Business

It's January 1st 2021; the final hours of the new year holiday, and after what 2020 was like, everyone is bent on squeezing the last bit of enjoyment before something else happens.

In the same breath, Nigerians are hoping they did not contract Covid when they threw caution to the wind while enjoying their December. 

They reminisce on how the world was only beginning to hear about the SARS-CoV-2 virus around this same time a year ago; how it broke healthcare systems and crashed economies—separating people from their workplaces and friends.

Everyone yearned for a vaccine—they dubbed it as the saviour back then. 

Over 170 research teams started the work to produce a vaccine. Towards the end of 2020, we saw preliminary results from vaccine trials. 

Pfizer Inc., one of the companies producing the Covid-19 vaccine, announced that it had recorded over 90% success rate on its trials. No company

This story is only available to Premium subscribers Subscribe or sign in to finish reading

Not ready to subscribe? Register to read a selection of free stories

Gbemisola Alonge

Gbemisola Alonge

Read Latest

Why local context matters for tech investors

PREMIUM - 26 NOV 2021

The untapped potential of Nigerian wind farms

PREMIUM - 25 NOV 2021

Why the eNaira is not yet useful to Nigerians

PREMIUM - 24 NOV 2021

Will telemedicine reverse Nigeria's medical brain drain?

PREMIUM - 23 NOV 2021